LGALS9 and cancer: Studies show that immune checkpoints TDO2, PDCD1, LGALS9, and PVR play an important role in cancer treatment and prognosis (Stamm et al., 2018; Fan et al., 2020; Miao et al., 2020; Cui et al., 2022).